A cost-effectiveness model for coronary thrombolysis/reperfusion therapy.
暂无分享,去创建一个
[1] P. Serruys,et al. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? , 1986, Circulation.
[2] R. Erbel,et al. Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. , 1986, Journal of the American College of Cardiology.
[3] H. Drexler,et al. Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex. , 1986, The American journal of cardiology.
[4] Y. Ohtsuki,et al. ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.
[5] E. Braunwald,et al. Management of the residual stenosis following thrombolytic therapy of acute myocardial infarction. , 1986, Cardiology.
[6] R. W. Brower,et al. Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. , 1986, Journal of the American College of Cardiology.
[7] G. Taylor,et al. Thrombolytic therapy followed by early revascularization for acute myocardial infarction. , 1986, The American journal of cardiology.
[8] J. Alpert,et al. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. , 1986, JAMA.
[9] P. Serruys,et al. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.
[10] P. Serruys,et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. , 1986, Journal of the American College of Cardiology.
[11] B. Pitt,et al. A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.
[12] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[13] I. Palacios,et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.
[14] E. Braunwald,et al. Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.
[15] C. G. Blomqvist,et al. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. , 1986, New England Journal of Medicine.
[16] T. Drake. Coronary thrombolysis with recombinant tissue-type plasminogen activator , 1986 .
[17] J. Spann,et al. Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. , 1986, The American journal of cardiology.
[18] M. Gotsman,et al. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.
[19] E. Braunwald,et al. High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial. , 1985, Journal of the American College of Cardiology.
[20] J. Douglas,et al. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. , 1985, Circulation.
[21] E. Gilpin,et al. Survival after hospital discharge in matched populations with inferior or anterior myocardial infarction. , 1985, Journal of the American College of Cardiology.
[22] D. McKee,et al. Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. , 1985, The American journal of cardiology.
[23] F. Sheehan,et al. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. , 1985, Journal of the American College of Cardiology.
[24] E. Braunwald. The aggressive treatment of acute myocardial infarction. , 1985, Circulation.
[25] F. Sheehan,et al. Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction. , 1985, Circulation.
[26] J L Ritchie,et al. The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.
[27] M. Verani,et al. Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial. , 1985, The American journal of cardiology.
[28] J. Arciniegas,et al. Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. , 1985, The American journal of cardiology.
[29] K. Karsch,et al. Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. , 1984, The New England journal of medicine.
[30] B E Sobel,et al. Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.
[31] J. Anderson,et al. Long-term follow-up after intracoronary streptokinase for myocardial infarction: a randomized, controlled study. , 1984, American heart journal.
[32] P. Mcmaster,et al. Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study. , 1984, Journal of the American College of Cardiology.
[33] S. M. Collins,et al. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. , 1984, Circulation.
[34] C. White,et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? , 1984, The New England journal of medicine.
[35] R. Schröder. Intravenous short-term infusion of streptokinase in acute myocardial infarction. , 1984, International journal of cardiology.
[36] A. Ross,et al. A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. , 1984, The American journal of cardiology.
[37] B. Rutherford,et al. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. , 1983, American heart journal.
[38] C. J. Kooijman,et al. Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. , 1983, British heart journal.
[39] J. Fleiss,et al. Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.
[40] I. Palacios,et al. Coronary reocclusion after selective administration of streptokinase. , 1983, Circulation.
[41] D. Berman,et al. Nonsurgical reperfusion in evolving myocardial infarction. , 1983, Journal of the American College of Cardiology.
[42] K. Wegscheider,et al. Intravenous Short‐term Infusion of Streptokinase in Acute Myocardial Infarction , 1983, Circulation.
[43] A. Maurer,et al. High-dose, brief intravenous streptokinase early in acute myocardial infarction. , 1982, American heart journal.
[44] P. Rentrop,et al. Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: complementary combined approach effecting reduced infarct size, preventing reinfarction, and improving left ventricular function. , 1981, American heart journal.
[45] S. D. Roberts,et al. Cost-effective care of end-stage renal disease: a billion dollar question. , 1980, Annals of internal medicine.
[46] M. Weinstein,et al. Allocation of Resources to Manage Hypertension , 1977 .
[47] S Cretin,et al. Cost/benefit analysis of treatment and prevention of myocardial infarction. , 1977, Health services research.